Skip to content
Stock screener

HTFL Heartflow, Inc. stock chart & analysis

Conviction 36HealthcareScan · Fri, Nov 13, 2026

Heartflow, Inc. (HTFL) closed at $48.33 (-19.34%) on Nov 13, 2026. Price is below its 50-day and above its 200-day moving average. RSI(14) 41, RS Rating 95, -20.3% from its 52-week high, +65.8% year to date. Sector: Healthcare · Health Information Services.

HTFL$48.33-19.34%
ResistanceSupportVol 14Insider sell
Loading chart…

Why HTFL moved

From the StockSetups movers recaps that covered HTFL, newest first. A recap states what was known that day.

Heartflow, Inc.Health Information Serviceswww.heartflow.com ↗
Price48.33
Change-19.34%
Gap-2.58%
Rel volume1.49×
Avg volume1.84M
Avg $ vol103.33M
SMA 2055.88
SMA 5051.91
SMA 20035.21
Price vs 50-6.90%
Price vs 200+37.26%
MA stackmixed
50/200 cross—
Supertrenddown · 62.07
RSI (14)41
MACD hist-0.60
MACD crossbear · 0d
Stoch %K / %D0 / 59
ADX (14)20
+DI / −DI20 / 28
RSI divergence—
MACD divergence—
ATR %8.11%
ADR %6.59%
52w high60.66
52w low20.13
From 52w high-20.32%
Above 52w low+140.09%
New 52w highNo
SqueezeOff
Bollinger width21.95%
%B-0.12
Donchian pos0.00%
Donchian high60.66
Donchian low48.33
AVWAP (52w high)56.86
vs AVWAP high-15.00%
AVWAP (52w low)37.63
vs AVWAP low+28.44%
OBV trendUp
Chaikin MF (20)0.13
Today vs 20d1.49×
Avg vol (14d)1.91M
Avg vol (20d)1.84M
Avg $ vol (20d)103.33M
Market cap4.25B
RS Rating95 / 99
RS 3m (vs SPY)+17.62%
RS 6m (vs SPY)+68.64%
RS line new highNo
Trend template7/8
Technical rank74.5
1 week-7.77%
1 month-5.06%
3 months+15.24%
6 months+70.69%
1 year+35.23%
YTD+65.80%
P/E-36.37
P/B15.03
P/S24.13
P/FCF-71.93
EPS-3.17
Div yield—
ROE-41.34%
ROA-32.87%
Debt/Eq—
Current4.41
EV/EBITDA-71.91
Gross margin76.80%
Net margin-66.35%
Rev growth39.92%
EPS growth-21.12%
Price target58.33
Target upside20.69%
Analyst ratingBuy
Institutional94.77%
Ent. value4.22B
Revenue72.86M
Net income-11.51M
Gross profit60.92M
Free cash flow-59.05M
IndustryHealth Information Services
ExchangeNasdaq
Shares out86.24M
Employees843
ListedFri, Aug 8, 2025
Free float54.61M
Float %64.1%
Short interest—
Days to cover—
Short volume60.5%
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est−$0.12 vs −$0.18
Last surprise+33.3% beat
Setup gradeD
Conviction36 / 100
Pattern quality—
Tech rank74.5 / 100
Group rank14 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance60.61
Support46.64
Days since event—
Candle confirm—

Financials as of Wed, Sep 30, 2026 · quarterly.

HTFL technical analysis

Trend

HTFL's moving averages are mixed — no clean uptrend or downtrend. It closed 6.9% below the 50-day ($51.91) and 37.3% above the 200-day ($35.21). ADX(14) at 20 points to a weak trend — more range than direction. It meets 7 of 8 trend-template criteria.

Momentum

RSI(14) is 41, in the bearish half of its range. MACD crossed below its signal line on the latest session. Its RS Rating of 95 puts its weighted 12-month performance ahead of about 95% of the US market.

Volume and volatility

Volume on the latest session ran 1.5× its 20-day average. It trades about $103.3M a day on average. ATR(14) is $3.92, 8.1% of price — its typical daily range. On-balance volume is trending up. Chaikin Money Flow (0.13) shows accumulation.

Key levels

The chart pattern's support is $46.64 and its resistance $60.61. The 52-week range is $20.13 to $60.66; price is 20.3% below the high and 140.1% above the low. The VWAP anchored at the 52-week high is $56.86, above price.

Performance

HTFL returned -7.8% (1 week), -5.1% (1 month), +15.2% (3 months), +70.7% (6 months), +35.2% (1 year), +65.8% (year to date).

About Heartflow, Inc.

HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.

Health Information Services · Listed 2025 · 843 employees

Insider activity

SEC Form 4 transactions in HTFL · open-market 2 sells

InsiderSideShares
Farquhar John C.M.
Chief Executive Officer · Stock Option · 2026-11-10
Exercise15.62K
Farquhar John C.M.
Chief Executive Officer · Common Stock · 2026-11-10
Exercise15.62K
Farquhar John C.M.
Chief Executive Officer · Common Stock · 2026-11-10
Sell38.9K
Verghese Vikram
Chief Financial Officer · Common Stock. · 2026-11-09
Sell3.59K
Rogers Campbell
Chief Medical Officer · Common Stock · 2026-11-06
Tax2.27K
Farquhar John C.M.
Chief Executive Officer · Common Stock · 2026-11-06
Tax7.75K
Jones Marie L.
Chief Accounting Officer · Common Stock. · 2026-11-06
Tax568
Verghese Vikram
Chief Financial Officer · Common Stock. · 2026-11-06
Tax2.01K
Jones Marie L.
Chief Accounting Officer · Common Stock. · 2026-09-08
Grant795
Rogers Campbell
Chief Medical Officer · Common Stock · 2026-10-22
Exercise12.33K

SEC filings

EDGAR filings in HTFL · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.

Start free — 7-day trial, no card →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.